Foghorn Therapeutics (NASDAQ:FHTX) reported its Q4 earnings results on Thursday, March 7, 2024 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Foghorn Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.57 versus an estimate of $-0.76.
Revenue …